Joe R. Delaney

4.4k total citations
33 papers, 862 citations indexed

About

Joe R. Delaney is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Joe R. Delaney has authored 33 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Joe R. Delaney's work include Autophagy in Disease and Therapy (7 papers), Cancer-related Molecular Pathways (6 papers) and RNA Research and Splicing (5 papers). Joe R. Delaney is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), Cancer-related Molecular Pathways (6 papers) and RNA Research and Splicing (5 papers). Joe R. Delaney collaborates with scholars based in United States, China and France. Joe R. Delaney's co-authors include Matt Kaeberlein, Brian K. Kennedy, Christopher J. Murakami, Vivian L. MacKay, Mark A. McCormick, Kristan K. Steffen, Dwayne G. Stupack, Robert R. Bowers, George L. Sutphin and Mitsuhiro Tsuchiya and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Joe R. Delaney

29 papers receiving 848 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joe R. Delaney United States 15 605 180 173 149 121 33 862
Beverley M. Dancy United States 12 883 1.5× 122 0.7× 118 0.7× 92 0.6× 142 1.2× 13 1.1k
Syuichi Takano Japan 13 766 1.3× 221 1.2× 148 0.9× 183 1.2× 149 1.2× 16 1.0k
Ludmila Kaplun United States 11 798 1.3× 145 0.8× 36 0.2× 151 1.0× 182 1.5× 16 1.1k
Nancy L. Maas United States 9 873 1.4× 220 1.2× 33 0.2× 148 1.0× 119 1.0× 10 1.1k
Xianglei Yin United States 11 464 0.8× 99 0.6× 78 0.5× 46 0.3× 64 0.5× 13 644
Ofer Moldavski United States 10 652 1.1× 289 1.6× 60 0.3× 159 1.1× 34 0.3× 11 970
Takao Toyomura Japan 9 745 1.2× 117 0.7× 60 0.3× 36 0.2× 73 0.6× 18 907
Andrea J. Hartlerode United States 8 960 1.6× 56 0.3× 101 0.6× 190 1.3× 317 2.6× 11 1.3k
Vittoria Zinzalla Italy 9 651 1.1× 114 0.6× 38 0.2× 50 0.3× 57 0.5× 12 737
Shabazz Muhammad United States 6 531 0.9× 62 0.3× 99 0.6× 234 1.6× 179 1.5× 6 1.1k

Countries citing papers authored by Joe R. Delaney

Since Specialization
Citations

This map shows the geographic impact of Joe R. Delaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe R. Delaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe R. Delaney more than expected).

Fields of papers citing papers by Joe R. Delaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe R. Delaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe R. Delaney. The network helps show where Joe R. Delaney may publish in the future.

Co-authorship network of co-authors of Joe R. Delaney

This figure shows the co-authorship network connecting the top 25 collaborators of Joe R. Delaney. A scholar is included among the top collaborators of Joe R. Delaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe R. Delaney. Joe R. Delaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
O’Malley, Matthew R., et al.. (2025). MYC and HSF1 Cooperate to Drive Sensitivity to Polo-like Kinase 1 Inhibitor Volasertib in High-grade Serous Ovarian Cancer. Cancer Research Communications. 5(2). 253–266.
3.
White‐Gilbertson, Shai, Ping Lü, Özge Saatci, et al.. (2024). Transcriptome analysis of polyploid giant cancer cells and their progeny reveals a functional role for p21 in polyploidization and depolyploidization. Journal of Biological Chemistry. 300(4). 107136–107136. 13 indexed citations
4.
Bowers, Robert R., Silvia G. Vaena, George Fullbright, et al.. (2024). MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model. Cancer Research Communications. 4(9). 2525–2538. 4 indexed citations
5.
Yin, Shasha, et al.. (2023). Autophagy dictates sensitivity to PRMT5 inhibitor in breast cancer. Scientific Reports. 13(1). 10752–10752. 9 indexed citations
6.
Delaney, Joe R.. (2023). RAC‐ing up tumour stemness: Disabled homolog 2 interacting protein and triple‐negative breast cancer. SHILAP Revista de lepidopterología. 3(1). 1 indexed citations
7.
Bowers, Robert R., et al.. (2022). SWAN pathway-network identification of common aneuploidy-based oncogenic drivers. Nucleic Acids Research. 50(7). 3673–3692. 13 indexed citations
8.
Bowers, Robert R., et al.. (2022). Autophagy modulating therapeutics inhibit ovarian cancer colony generation by polyploid giant cancer cells (PGCCs). BMC Cancer. 22(1). 410–410. 26 indexed citations
9.
Yin, Shasha, et al.. (2022). Arginine methylation of BRD4 by PRMT2/4 governs transcription and DNA repair. Science Advances. 8(49). eadd8928–eadd8928. 27 indexed citations
10.
Helke, Kristi L., Radhika Gudi, Chenthamarakshan Vasu, & Joe R. Delaney. (2022). Combination of Autophagy Selective Therapeutics With Doxil: An Assessment of Pathological Toxicity. SHILAP Revista de lepidopterología. 4. 937150–937150.
11.
Świtoński, Paweł M., Joe R. Delaney, Luke C. Bartelt, et al.. (2021). Altered H3 histone acetylation impairs high-fidelity DNA repair to promote cerebellar degeneration in spinocerebellar ataxia type 7. Cell Reports. 37(9). 110062–110062. 10 indexed citations
12.
White‐Gilbertson, Shai, Ping Lü, S Chiodini, et al.. (2020). Tamoxifen is a candidate first‐in‐class inhibitor of acid ceramidase that reduces amitotic division in polyploid giant cancer cells—Unrecognized players in tumorigenesis. Cancer Medicine. 9(9). 3142–3152. 45 indexed citations
13.
Lee, Chang‐Lung, Yvonne M. Mowery, Andrea R. Daniel, et al.. (2019). Mutational landscape in genetically engineered, carcinogen-induced, and radiation-induced mouse sarcoma. JCI Insight. 4(13). 37 indexed citations
14.
Axelrod, J & Joe R. Delaney. (2017). Pathways to Genome-targeted Therapies in Serous Ovarian Cancer.. PubMed. 3(7). 1 indexed citations
15.
Stupack, Dwayne G., et al.. (2016). Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings. Drug Design Development and Therapy. 10. 1837–1837. 14 indexed citations
16.
17.
McCabe, Katelyn E., Alena Bartáková, Joe R. Delaney, et al.. (2015). Integrin α4 Enhances Metastasis and May Be Associated with Poor Prognosis in MYCNlow Neuroblastoma. PLoS ONE. 10(5). e0120815–e0120815. 22 indexed citations
18.
Labunskyy, Vyacheslav M., Maxim V. Gerashchenko, Joe R. Delaney, et al.. (2014). Lifespan Extension Conferred by Endoplasmic Reticulum Secretory Pathway Deficiency Requires Induction of the Unfolded Protein Response. PLoS Genetics. 10(1). e1004019–e1004019. 64 indexed citations
19.
Sutphin, George L., Joe R. Delaney, & Matt Kaeberlein. (2014). Replicative Life Span Analysis in Budding Yeast. Methods in molecular biology. 1205. 341–357. 4 indexed citations
20.
Nelson, James A., et al.. (2008). 250 W HVHBT Doherty With 57% WCDMA Efficiency Linearized to ${-}$55 dBc for 2c11 6.5 dB PAR. IEEE Journal of Solid-State Circuits. 43(10). 2218–2228. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beverley M. Dancy Breakdown of academic impact, for papers by Syuichi Takano Breakdown of academic impact, for papers by Ludmila Kaplun Breakdown of academic impact, for papers by Nancy L. Maas Breakdown of academic impact, for papers by Xianglei Yin Breakdown of academic impact, for papers by Ofer Moldavski Breakdown of academic impact, for papers by Takao Toyomura Breakdown of academic impact, for papers by Andrea J. Hartlerode Breakdown of academic impact, for papers by Vittoria Zinzalla Breakdown of academic impact, for papers by Shabazz Muhammad
Rankless by CCL
2026